Peter Morand
President at Peter Morand & Associates, Inc.
Profile
Peter Morand is currently a Director at the Institute on Governance, Folia Biotech, Inc., Feldan Bio, Inc., and President of Dr. Morand & Associates, Inc. He previously served as President & CEO of Canadian Science & Technology Growth Fund, Inc. from 1996 to 2005.
He was also a Director at Fennec Pharmaceuticals, Inc. from 1998 to 2009, and at D-Box Technologies, Inc. from 2004 to 2006.
Additionally, he served as Chairman of SOVAR, Inc., and as a Director at Variation Biotechnologies (US), Inc., Ottawa Life Sciences Council, and the University of Ottawa where he was Dean of Science & Engineering.
From 1990 to 1995, he was the President of the Natural Sciences & Engineering Research Council of Canada.
Peter Morand active positions
| Companies | Position | Start |
|---|---|---|
Peter Morand & Associates, Inc.
 Peter Morand & Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Peter Morand & Associates, Inc. provides business consulting services. The private company is based in Ottawa, Canada. | President | - |
| Institute on Governance | Director/Board Member | - |
Folia Biotech, Inc.
 Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | Director/Board Member | - |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Director/Board Member | - |
Former positions of Peter Morand
| Companies | Position | End |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Director/Board Member | 07/07/2009 |
| Ottawa Life Sciences Council | Director/Board Member | 02/01/2007 |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Director/Board Member | 01/01/2007 |
| D-BOX TECHNOLOGIES INC. | Director/Board Member | 01/01/2006 |
| Canadian Science & Technology Growth Fund, Inc. | President | 01/01/2005 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FENNEC PHARMACEUTICALS INC. | Health Technology |
| D-BOX TECHNOLOGIES INC. | Consumer Durables |
| Private companies | 9 |
|---|---|
| Canadian Science & Technology Growth Fund, Inc. | Finance |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
Natural Sciences & Engineering Research Council of Canada
 Natural Sciences & Engineering Research Council of Canada General GovernmentGovernment Natural Sciences & Engineering Research Council of Canada operates as a funding agency for university based research and student training in natural sciences and engineering. The company was founded on May 1, 1978 and is headquartered in Mississauga, Canada. | Government |
SOVAR, Inc.
 SOVAR, Inc. Miscellaneous Commercial ServicesCommercial Services SOVAR, Inc. provides development and commercialization of new technologies derived from university research and from partnering research centre. It specializes in identifying novel technologies and expertise derived from research activities, develop them and facilitate their transfer into useful and marketable applications. The company was founded in 2000 and is headquartered in St. Foy, Canada. | Commercial Services |
Peter Morand & Associates, Inc.
Peter Morand & Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Peter Morand & Associates, Inc. provides business consulting services. The private company is based in Ottawa, Canada. | Commercial Services |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | Retail Trade |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Health Technology |
| Institute on Governance | |
| Ottawa Life Sciences Council |
- Stock Market
- Insiders
- Peter Morand
